ArticleiScience2026
LncRNA
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial infarction (MI) is a severe global health issue with high morbidity and mortality. Recent studies highlight the critical role of lncRNAs in recovery following MI but the molecular mechanisms remain largely unclear. In this study, we identified a novel lncRNA, cardiac autophagy contributory factor (CACF), in an MI model of miniature pigs. Our results demonstrate that CACF promotes angiogenesis in vascular cells by modulating autophagy through miR-520b-3p and miR-20a-5p. CACF binds negatively to miR-520b-3p and miR-20a-5p, upregulating ATG7 to enhance autophagy and cardiac recovery. This mechanism promotes cell proliferation and inhibits apoptosis in vascular cells. Notably, miR-20a-5p increases cell proliferation and reduces apoptosis, while miR-520b-3p inhibits proliferation and promotes apoptosis. Both miRNAs suppress autophagy. The interplay among CACF, miR-520b-3p, miR-20a-5p, and ATG7 reveals a complex regulatory network that enhances autophagy and cardiac repair after MI. These findings provide potential insights for therapeutic strategies in MI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.